POUGHKEEPSIE, NY--(Marketwire - July 18, 2007) - The publisher of Laboratory Economics has just released The U.S. Anatomic Pathology Market: Forecast & Trends 2007. With this special report, you can tap into 100 pages of proprietary market research that reveals critical data and information about key business trends affecting the anatomic pathology market.

The report reveals that the anatomic pathology market (including Pap testing) now represents an estimated $11.3 billion of revenue with an annual growth rate of 9%. With five-year historical data and a detailed five-year forecast, all data and trends are fully explained throughout the report.

The U.S. anatomic pathology market is expected to remain robust. "The introduction of new higher-priced cancer tests should more than offset pricing pressure from Medicare and private payers on traditional pathology tests," according to Jondavid Klipp, publisher of Laboratory Economics.

The report includes:

--  More than 60 charts and graphs
--  Industry size and growth rates
--  Detailed estimates for market subsets like prostate cancer testing,
    dermatopathology, lymphoma/leukemia and gastrointestinal pathology
--  Medicare claims data for key pathology codes
--  Liquid Pap test trends and pricing data
--  In-office histology lab trends
--  Latest Pod Lab developments
--  First-hand perspectives from 11 pathology company executives
Also featured are in-depth profiles on the anatomic pathology companies: AmeriPath, Bio-Reference Labs, Clarient Inc., Genomic Health, Genzyme Genetics, Myriad Genetics, LabCorp, Neogenomics and Quest Diagnostics.

The U.S. Anatomic Pathology Market: Forecast & Trends 2007 is published by Laboratory Economics (www.laboratoryeconomics.com), an independent market research firm focused exclusively on the business of pathology and laboratory medicine.

Contact Information: Contact: Jondavid Klipp President Laboratory Economics 195 Kingwood Park Poughkeepsie, NY 12601 Phone: 845-463-0080 www.laboratoryeconomics.com